Eisai
4523.T
#2011
Rank
ยฃ6.20 B
Marketcap
ยฃ22.00
Share price
-0.53%
Change (1 day)
-42.32%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Revenue for Eisai (4523.T)

Revenue in 2024 (TTM): ยฃ4.03 Billion

According to Eisai's latest financial reports the company's current revenue (TTM ) is ยฃ4.02 Billion. In 2023 the company made a revenue of ยฃ4.15 Billion a decrease over the revenue in the year 2022 that were of ยฃ4.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eisai from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ4.03 B-2.88%
2023 ยฃ4.15 B-9.56%
2022 ยฃ4.59 B-2.59%
2021 ยฃ4.71 B-3.69%
2020 ยฃ4.89 B5.81%
2019 ยฃ4.62 B3.11%
2018 ยฃ4.48 B19.45%
2017 ยฃ3.75 B-5.84%
2016 ยฃ3.98 B25.95%
2015 ยฃ3.16 B-5.26%
2014 ยฃ3.34 B-7.14%
2013 ยฃ3.59 B-17.48%
2012 ยฃ4.36 B-18.59%
2011 ยฃ5.35 B-11.95%
2010 ยฃ6.08 B17.85%
2009 ยฃ5.16 B